Search Results

Robert J Lefkowitz and team's study 'GPCR signal transduction: β-arrestin activates ERK MAPK.' Dr. J. Silvio Gutkind.

Michel Bouvier, J Silvio Gutkind, and team found that Gαs is essential for GRK selectivity and gene regulation cardiometabolic diseases GPCR Events, Meetings, and Webinars October 2 - 3, 2023 | Celebrating Robert J.

work on Conformational dynamics underlying atypical chemokine receptor 3 activation Michael Trogdon, J Silvio Gutkind, Edward C Stites, et al., for their study on Systems modeling of oncogenic G-protein and

Silvio Gutkind on G protein hotspot mutations, why the canonical GαQ pathway fails in uveal melanoma, and how CXCR3 may gate immunotherapy response. << Back to podcast list Strategic Partner(s) Silvio Gutkind J Silvio Gutkind, a class on oncogenes and his interests for GPCRs helped shape his scientific interests J. Silvio Gutkind on the web Dr. J Silvio Gutkind on LinkedIn Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications

Silvio Gutkind on keeping a cancer research lab running at 10% occupancy, why rotation students act like Silvio Gutkind is Professor and Associate Director for Basic Science at the UCSD Moores Cancer Center J. Silvio Gutkind sheds light on his work and life since the beginning of COVID restrictions. Silvio Gutkind on the web Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications More J Silvio Gutkind on LinkedIn Gutkind Lab on Twitter UCSD Moores Cancer Center Dr.

Nicola J. Smith About Dr. Nicola J. Smith Dr. Nicola J Smith is an expert in molecular pharmacology with a track record in exploring GPCR structure-function Nicola J. Smith on the web UNSW Sydney LinkedIn Retraction Watch Twitter Dr.